secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001809519-24-000104
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx stockholders elect three Class I directors, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------------

- Elected Douglas Hirsch, Kelly J. Kennedy, and Agnes Rey-Giraud as Class I directors for terms through 2027.
- Ratified appointment of PricewaterhouseCoopers LLP as independent auditor for fiscal 2024.
- Advisory vote approved named executive officer compensation (2.82B votes for, 4.15M against).
- Over 98.7% of combined voting power represented at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000104/0001809519-24-000104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000104/gdrx-20240606.htm
  HTML page:      https://secwatch.observer/filing/0001809519-24-000104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer